Percent with outcome | ||||||||
Reference | Condition treated | Topical treatment | Studies/Participants | Active | Placebo | RR 95% CI | NNH 95% CI |
GRADE (review‐reported) |
Acute pain conditions | ||||||||
Pattanittum 2013 | Lateral elbow pain | Diclofenac | 3/153 | 2 | 1 | 1.6 (0.2 to 12) | n/c | Low quality |
Derry 2015 (Systemic adverse events) |
Strains and sprains | All NSAIDs | 36/5576 | 3 | 4 | 1.0 (0.7 to 1.3) | n/c | High quality |
Chronic pain conditions | NNH | |||||||
Wrzosek 2015 | Neuropathic pain | Clonidine | 2/344 | 12 | 13 | 0.7 (0.1 to 3.1) | n/c | Very low quality |
Derry 2016 (Systemic adverse events) |
Knee and hand OA | Diclofenac | 7/1266 | 6 | 7 | 0.9 (0.6 to 1.3) | n/c | Very low quality |
Acute and chronic pain conditions | NNH | |||||||
Derry 2014b | OA or LBP | Salicylate | 11/984 | 15 | 9 | 1.6 (1.2 to 2.0) | 17 (9.9 to 58) | Low quality |